Welcome to LookChem.com Sign In|Join Free
  • or
N-[(1S)-2-amino-2-oxo-1-(phenylmethyl)ethyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide is a complex organic compound with a unique molecular structure. It is an indazole derivative characterized by its potential pharmaceutical applications and interactions with specific biological targets.

1185282-03-4

Post Buying Request

1185282-03-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1185282-03-4 Usage

Uses

Used in Pharmaceutical Industry:
N-[(1S)-2-amino-2-oxo-1-(phenylmethyl)ethyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide is used as a CB1 receptor modulator for the treatment of CB1-mediated diseases. Its molecular structure allows it to interact with the CB1 receptor, which plays a crucial role in various physiological processes and conditions.
Used in Synthetic Cannabinoid Research:
As an analog of AB-FUBINACA, N-[(1S)-2-amino-2-oxo-1-(phenylmethyl)ethyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide is used in the research and development of synthetic cannabinoids. These synthetic cannabinoids have potential applications in the treatment of various conditions, including pain management and the alleviation of symptoms associated with multiple sclerosis and other neurological disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 1185282-03-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,8,5,2,8 and 2 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1185282-03:
(9*1)+(8*1)+(7*8)+(6*5)+(5*2)+(4*8)+(3*2)+(2*0)+(1*3)=154
154 % 10 = 4
So 1185282-03-4 is a valid CAS Registry Number.

1185282-03-4Downstream Products

1185282-03-4Relevant academic research and scientific papers

INDAZOLE DERIVATIVES

-

, (2011/02/25)

This invention relates to compounds, pharmaceutical compositions and methods for the treatment of a condition mediated by CB1 receptor activity in a mammalian subject including a human, which comprises administering to a mammal in need of such treatment a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1185282-03-4